SCHOTT Pharma AG & Co. KGaA: Christian Mias to succeed Andreas Reisse as CEO
Veröffentlicht: 05.11.2025 um 17:56 Uhr, dgap.de| EQS-Ad-hoc: SCHOTT Pharma AG & Co. KGaA / Key word(s): Personnel SCHOTT Pharma AG & Co. KGaA: Christian Mias to succeed Andreas Reisse as CEO 05-Nov-2025 / 17:56 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group. The issuer is solely responsible for the content of this announcement. The Supervisory Board of SCHOTT Pharma Management AG has today appointed Christian Mias as the new Chief Executive Officer (CEO) of SCHOTT Pharma, effective May 1, 2026. He will succeed Andreas Reisse, who will retire as planned at the end of April 2026. Christian Mias has held various management positions within the SCHOTT Group since 2007, most recently serving as Head of the Business Unit Electronic Packaging. End of Inside Information 05-Nov-2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. View original content: EQS News |
| Language: | English |
| Company: | SCHOTT Pharma AG & Co. KGaA |
| Hattenbergstraße 10 | |
| 55122 Mainz | |
| Germany | |
| ISIN: | DE000A3ENQ51 |
| WKN: | A3ENQ5 |
| Indices: | SDAX |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 2224602 |
| End of Announcement | EQS News Service |
| |
2224602 05-Nov-2025 CET/CEST
en | DE000A3ENQ51 | SCHOTT PHARMA AG & CO. KGAA | boerse | 68325633 |
